SCHEDULE 13G/A: Nantahala Capital Partners Discloses 2.2% Stake in Surrozen, Inc.
Beneficial Ownership Report
Nantahala Capital Partners Limited Partnership has filed an amended Schedule 13G, reporting a 2.2% beneficial ownership stake in Surrozen, Inc. as of March 31, 2025.
Summary
- Nantahala Capital Partners Limited Partnership (Nantahala) has filed an Amendment No. 1 to Schedule 13G regarding its beneficial ownership in Surrozen, Inc./DE.
- As of March 31, 2025, Nantahala beneficially owns an aggregate of 73,918 shares of Surrozen, Inc.'s Common Stock.
- This ownership represents 2.2% of the total class outstanding, based on 3,281,169 shares outstanding as reported by Surrozen, Inc. in its Form 10-K filed on April 2, 2025.
- The 73,918 shares include 33,561 shares that can be acquired by Nantahala within sixty days through the exercise of warrants.
- Nantahala holds shared voting power and shared dispositive power over all 73,918 shares.
- The filing certifies that the securities were not acquired or held for the purpose of changing or influencing the control of Surrozen, Inc.
Sentiment
Score: 5
Explanation: The document is a neutral, factual report of beneficial ownership, indicating a passive investment stake. It contains no positive or negative operational or financial news about the issuer.
Future Outlook
The document does not contain any forward-looking statements or guidance regarding Surrozen, Inc.'s future performance or strategic direction.
Industry Context
This filing is a routine disclosure of beneficial ownership by an investment firm in a publicly traded biotechnology company. It does not provide insights into broader industry trends or competitive landscape, focusing solely on the ownership stake.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake, confirming a passive investment approach by Nantahala Capital Partners.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement (beneficial ownership calculation date). |
| 04/02/2025 | Date Surrozen, Inc. filed its Form 10-K, providing the basis for total shares outstanding. |
| 05/15/2025 | Date the Schedule 13G Amendment No. 1 was signed and filed by Nantahala Capital Partners. |
Keywords
Surrozen Inc., Nantahala Capital Partners, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Investment, Biotechnology, Pharmaceuticals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.